Evidence map›Paper›PMID 30463298›Full record

ArticleInternational journal of molecular sciences2018

Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and HspB5 from Endothelial RBE4 Cells.

Giuseppe Caruso, Claudia G Fresta, Giacomo Lazzarino, Donatella A Distefano, Paolo Parlascino, Susan M Lunte, Giuseppe Lazzarino, Filippo Caraci

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Peptidergic Systems and Neuroblastoma.International journal of molecular sciences · 2025
    Review
  2. Article
  3. The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms.Current research in pharmacology and drug discovery · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Giuseppe CarusoOasi Research Institute-IRCCS, 94018 Troina, Italy. forgiuseppecaruso@gmail.com.ORCID 0000-0003-1571-5327
Claudia G FrestaRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS 66045, USA. forclaudiafresta@gmail.com.
Giacomo LazzarinoInstitute of Biochemistry and Clinical Biochemistry, Catholic University of the Sacred Heart, 00168 Rome, Italy. g.lazzarino@libero.it.
Donatella A DistefanoDepartment of Biomedical and Biotechnological Sciences, Division of Medical Biochemistry, University of Catania, 95125 Catania, Italy. donadist@hotmail.it.
Paolo ParlascinoDepartment of Biomedical and Biotechnological Sciences, Division of Medical Biochemistry, University of Catania, 95125 Catania, Italy. paolo.parlascino22@gmail.com.
Susan M LunteRalph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS 66045, USA. slunte@ku.edu.
Giuseppe LazzarinoDepartment of Biomedical and Biotechnological Sciences, Division of Medical Biochemistry, University of Catania, 95125 Catania, Italy. lazzarig@unict.it.ORCID 0000-0002-5917-7279
Filippo CaraciOasi Research Institute-IRCCS, 94018 Troina, Italy. carafil@hotmail.com.
University of Catania · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Kansas · USOasi Maria SS · IT

Funding

Understanding the mechanobiology of stem cells in a microengineered 3D cardiac tissue environment with cardiomyopathyP20GM103638 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LUNTE, SUSAN M · 2012 to 2021
$22.1M
American Heart Association NFP0075515National Institutes of Health P20GM103638National Science Foundation CHE-1411993Neuropsychopharmacology Research Program 2017 RC-06-05NIGMS NIH HHS P20 GM103638
6 · The paper itself

Abstract

Human amylin is a 37-residue peptide hormone (hA1-37) secreted by β-cells of the pancreas and, along with insulin, is directly associated with type 2 diabetes mellitus (T2DM). Amyloid deposits within the islets of the pancreas represent a hallmark of T2DM. Additionally, amylin aggregates have been found in blood vessels and/or brain of patients with Alzheimer's disease, alone or co-deposited with β-amyloid. The purpose of this study was to investigate the neuroprotective potential of human amylin in the context of endothelial-neuronal "cross-talk". We initially performed dose-response experiments to examine cellular toxicity (quantified by the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] MTT assay) of different hA17⁻29 concentrations in endothelial cells (RBE4). In the culture medium of these cells, we also measured heat shock protein B5 (HspB5) levels by ELISA, finding that even a sub-toxic concentration of hA17⁻29 (3 µM) produced an increase of HspB5. Using a cell medium of untreated and RBE4 challenged for 48 h with a sub-toxic concentration of hA17⁻29, we determined the potential beneficial effect of their addition to the medium of neuroblastoma SH-SY5Y cells. These cells were subsequently incubated for 48 h with a toxic concentration of hA17⁻29 (20 µM). We found a complete inhibition of hA17⁻29 toxicity, potentially related to the presence in the conditioned medium not only of HspB5, but also of vascular endothelial growth factor (VEGF). Pre-treating SH-SY5Y cells with the anti-Flk1 antibody, blocking the VEGF receptor 2 (VEGFR2), significantly decreased the protective effects of the conditioned RBE4 medium. These data, obtained by indirectly measuring VEGF activity, were strongly corroborated by the direct measurement of VEGF levels in conditioned RBE4 media as detected by ELISA. Altogether, these findings highlighted a novel role of sub-toxic concentrations of human amylin in promoting the secretion of proteic factors by endothelial cells (HspB5 and VEGF) that support the survival and proliferation of neuron-like cells.

Indexed as

AmyloidAnimalsCell Line, TumorCell ProliferationCell SurvivalCrystallinsCulture Media, ConditionedEndothelial CellsFluorescenceHumansIslet Amyloid PolypeptideMicrotubule-Associated ProteinsProtein AggregatesRatsTime FactorsVascular Endothelial Growth Factor AAmyloidcryaB protein, ratCrystallinsCulture Media, ConditionedIslet Amyloid PolypeptideMicrotubule-Associated ProteinsProtein AggregatesVascular Endothelial Growth Factor AAlzheimer’s diseaseamylinHspB5neuroprotectionvascular endothelial growth factorβ-amyloid

Identifiers

PMID30463298
PMCPMC6274958
OpenAlexW2901884182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.